Marc H. Graboyes

Marc H. Graboyes discloses dealings in Allos Therapeutics Inc to SEC (Form 4). In total, 29 filings cover trades dated from 30 December 2005 to 4 September 2012.

In open-market terms, that means 4 purchases worth €11k on one side and 13 sales worth €1.2M on the other. Netting one side against the other leaves €1.2M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 5 share grants and 6 option exercises. Since January 2012: no purchases and 4 sales on the market.

Half of the purchases are above €3,068 and half below.

The newest entry dates from 5 September 2012: a transaction of €787k, in Allos Therapeutics Inc. The latest purchase dates back some time: it was published 5,958 days ago, on 2 July 2010. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.